Stay updated with breaking news from Lpcn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a report issued on Saturday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of LPCN stock opened at $4.76 on Friday. Lipocine has a 52-week low of $3.30 and a 52-week high of $14.53. […]
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note published on Friday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of NASDAQ:LPCN opened at $4.85 on Friday. The firm has a market capitalization of $25.22 million, a PE ratio of […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research report sent to investors on Thursday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Lipocine stock opened at $4.30 on Thursday. Lipocine has a fifty-two week low of $3.30 and a fifty-two week […]
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note released on Wednesday. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Up 4.4 % Shares of NASDAQ:LPCN opened at $4.50 on Wednesday. The company has a market capitalization of $23.40 million, a PE ratio […]
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a report issued on Wednesday. The firm set a “buy” rating on the specialty pharmaceutical company’s stock. Lipocine Stock Down 6.9 % Shares of Lipocine stock opened at $4.31 on Wednesday. The firm has a market cap of $22.41 million, a P/E ratio […]